about
TNF-alpha inhibitors for psoriatic arthritisBeneficial effect of real-time continuous glucose monitoring system on glycemic control in type 1 diabetic patients: systematic review and meta-analysis of randomized trialsContinuous Glucose Monitoring System in children with type 1 diabetes mellitus: a systematic review and meta-analysis.Meta-analysis: zinc supplementation for acute gastroenteritis in children.Influence of the treatment of developmental dysplasia of the hip by the abduction brace on locomotor development in children.Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets.Validity of EQ-5D-5L in stroke.The beneficial effect of insulin degludec on nocturnal hypoglycaemia and insulin dose in type 1 diabetic patients: a systematic review and meta-analysis of randomised trials.Comparing responsiveness of the EQ-5D-5L, EQ-5D-3L and EQ VAS in stroke patients.Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study.Patient's age rather than severity of the arrhythmia influences the cost of medical treatment of atrioventricular nodal or atrioventricular reciprocating tachycardiaEQ-5D-5L Polish population normsGender-related differences in outcomes and resource utilization in patients undergoing radiofrequency ablation of supraventricular tachycardia: results from Patients' Perspective on Radiofrequency Catheter Ablation of AVRT and AVNRT Study.Translation and cultural adaptation of the Polish version of the Disabilities of the Arm, Shoulder and Hand (DASH) and QuickDASH questionnaires.EQ-5D studies in musculoskeletal and connective tissue diseases in eight Central and Eastern European countries: a systematic literature review and meta-analysis.EQ-5D in Central and Eastern Europe: 2000-2015.The impact of a belief in life after death on health-state preferences: True difference or artifact?Quality of life in patients with type 2 diabetes in Poland - comparison with the general population using the EQ-5D questionnaire.Translation and cultural adaptation of a Patient Perception of Arrhythmia Questionnaire in Poland.Quality of life in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention--radial versus femoral access (from the OCEAN RACE Trial).Quality of life improvement after radiofrequency catheter ablation of outflow tract ventricular arrhythmias in patients with structurally normal heart.EQ-5D studies in cardiovascular diseases in eight Central and Eastern European countries: a systematic review of the literature.Annual Cost Of Conservative Treatment Of Supraventricular Tachycardias In Poland.Validity of the Eq-5d-5l in Stroke Patients.Valuation of EQ-5D Health States in Poland: First TTO-Based Social Value Set in Central and Eastern EuropeThe burden of informal caregiving in Hungary, Poland and Slovenia: results from national representative surveys.What Influences Recommendations Issued by the Agency for Health Technology Assessment in Poland? A Glimpse Into Decision Makers' Preferences.Towards a Central-Eastern European EQ-5D-3L population norm: comparing data from Hungarian, Polish and Slovenian population studies.A comparison of European, Polish, Slovenian and British EQ-5D-3L value sets using a Hungarian sample of 18 chronic diseases.Interim EQ-5D-5L Value Set for Poland: First Crosswalk Value Set in Central and Eastern EuropeDevelopment of Population Tariffs for the CarerQol Instrument for Hungary, Poland and Slovenia: A Discrete Choice Experiment Study to Measure the Burden of Informal CaregivingEQ-5D studies in nervous system diseases in eight Central and East European countries: a systematic literature reviewValuation of EQ-5D-5L Health States in Poland: the First EQ-VT-Based Study in Central and Eastern Europe
P50
Q24240905-681A44BE-7784-4252-BC27-FB0E1792EC1CQ26824430-C4728069-DDC1-474B-96B1-B20585AB1534Q33308776-21D61327-7C0E-4459-80FA-E42D46AB7B4BQ33400017-6B89BBBB-F2B7-446A-8C2F-FD680C71A3B9Q33611654-2C51176F-EA80-4E14-87D4-B78ABFA6DB7FQ34292493-640DCFE9-3905-4173-AADE-EE58EF8DD531Q35197189-F970F2C2-9653-4CAF-84D6-F41688E950D5Q35457098-FBC292FE-6585-4571-A136-42884D680028Q35687316-ABC45C5B-040C-4D39-B17B-6620759E2C99Q37150150-06AC9C71-D1A7-4CDF-A118-072E24C07513Q37366163-75BD6360-24C1-49D6-849E-D91C083DFEC7Q37549309-92F03233-415C-4975-AAF3-BF59A13C0AB8Q38219558-C0EFEBE6-FF24-48FA-8523-8701EEFACFABQ38420730-DC316945-45B0-4F46-B9E3-A4683083220FQ38636348-B5082362-0567-46DD-A8E5-789C313587B0Q38912637-E52D105C-50A9-4122-999A-1ABA60DA6CE9Q39573826-D3447EC7-6A4D-4938-8FBA-EC70B4240500Q41000584-67FC610F-F6A6-4520-8AD8-7D67441A4777Q43545305-5D415609-5D66-4647-95FE-8A9FF94A17ADQ48070996-A8F4E115-CB5E-4362-865B-AF3DF6461FC3Q48436184-6FA09796-5B4D-47E1-B6DE-7F393684D420Q48513894-96C43B05-E36D-407C-B021-6A28F5A4631AQ51309519-FC31E03B-4744-42D4-89B1-E5867872F196Q53726670-ADDA3AC7-E471-471D-A5B9-2A6E771BB28FQ60629810-95E1DDC6-FEA0-4DA0-85A7-DD6F3099BD30Q64904367-FBFA156A-62C0-4D65-816B-5818A0668EE9Q64960883-F59869A5-95B8-4195-AC2B-BE5F051ED495Q64968601-87F18191-7590-4FE4-A475-D8D602002FC6Q64981700-C81FE0D5-6F11-4466-9F93-031D7881C2EFQ88495344-598A5BAE-B1EE-46E7-A6E9-8B2AFAAB4662Q90580467-807C7C22-D21D-4223-A68C-03C369D42C6FQ92102042-22024B52-4514-4F37-AA95-4D85E066CB02Q92507488-069E06DB-BE5F-43FB-8995-9478122A7B96
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Dominik Golicki
@ast
Dominik Golicki
@en
Dominik Golicki
@es
Dominik Golicki
@nl
Dominik Golicki
@sl
type
label
Dominik Golicki
@ast
Dominik Golicki
@en
Dominik Golicki
@es
Dominik Golicki
@nl
Dominik Golicki
@sl
prefLabel
Dominik Golicki
@ast
Dominik Golicki
@en
Dominik Golicki
@es
Dominik Golicki
@nl
Dominik Golicki
@sl
P214
P106
P1153
24597559500
P214
P31
P496
0000-0001-7741-4760
P7859
viaf-313518618